Krystal Biotech, Inc.(KRYS)
Biotechnology
Gene Therapy & Gene Editing
Recent Insider Trades
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-26 | Thomas John Charles EVP, General Counsel | Sale | -1,000 | -100.00%0 | $347.27 | $347,270 | View SEC filing | |
| 2026-06-05 | Krishnan Suma President, R&D | Sale | -25,000 | -1.50%1,639,505 | $308.11 | $7,702,825 | View SEC filing | |
| 2026-06-05 | Krishnan Krish S President and CEO | Sale | -25,000 | -1.41%1,748,778 | $308.12 | $7,702,984 | View SEC filing | |
| 2026-05-27 | Thomas John Charles EVP, General Counsel | Sale | -642 | -100.00%0 | $302.03 | $193,903 | View SEC filing | |
| 2026-03-06 | Krishnan Suma President, R&D | Sale | -25,000 | -1.59%1,544,855 | $263.21 | $6,580,270 | View SEC filing | |
| 2026-03-06 | Krishnan Krish S President and CEO | Sale | -25,000 | -1.52%1,616,173 | $263.17 | $6,579,164 | View SEC filing | |
| 2026-03-03 | ROMANO KATHRYN Chief Accounting Officer | Sale | -750 | -3.24%22,366 | $267.60 | $200,700 | View SEC filing | |
| 2026-03-03 | JANNEY DANIEL Director | Sale | -11,803 | -13.87%73,293 | $275.59 | $3,252,824 | View SEC filing | |
| 2026-02-26 | JANNEY DANIEL Director | Sale | -60,161 | -41.31%85,469 | $268.44 | $16,149,383 | View SEC filing | |
| 2026-02-23 | ROSSI DINO A Director | Sale | -18,950 | -19.41%78,691 | $261.41 | $4,953,694 | View SEC filing | |
| 2026-02-11 | ROMANO KATHRYN Chief Accounting Officer | Sale | -12,500 | -40.23%18,568 | $272.14 | $3,401,705 | View SEC filing | |
| 2025-12-05 | Krishnan Suma President, R&D | Sale | -50,000 | -1.62%3,031,767 | $220.15 | $11,007,333 | View SEC filing | |
| 2025-12-05 | Krishnan Krish S President and CEO | Sale | -50,000 | -1.62%3,031,767 | $220.15 | $11,007,447 | View SEC filing | |
| 2025-07-16 | Krishnan Suma President, R&D | Sale | -35,873 | -1.15%3,086,767 | $150.39 | $5,395,001 | View SEC filing | |
| 2025-07-16 | Krishnan Krish S President and CEO | Sale | -35,873 | -1.15%3,086,767 | $150.39 | $5,395,001 | View SEC filing | |
| 2025-07-11 | Krishnan Suma President, R&D | Sale | -14,127 | -0.45%3,122,640 | $150.27 | $2,122,835 | View SEC filing | |
| 2025-07-11 | Krishnan Krish S President and CEO | Sale | -14,127 | -0.45%3,122,640 | $150.27 | $2,122,835 | View SEC filing | |
| 2025-03-13 | Krishnan Suma President, R&D | Sale | -50,000 | -1.57%3,138,023 | $177.79 | $8,889,525 | View SEC filing | |
| 2025-03-13 | Krishnan Krish S President and CEO | Sale | -50,000 | -1.57%3,138,098 | $177.79 | $8,889,525 | View SEC filing | |
| 2025-02-28 | ROMANO KATHRYN Chief Accounting Officer | Sale | -750 | -3.74%19,318 | $175.22 | $131,415 | View SEC filing | |
| 2024-12-13 | Krishnan Suma President, R&D | Sale | -50,000 | -1.56%3,153,144 | $164.80 | $8,240,023 | View SEC filing | |
| 2024-12-13 | Krishnan Krish S President and CEO | Sale | -50,000 | -1.55%3,172,202 | $164.80 | $8,240,023 | View SEC filing | |
| 2024-09-13 | Krishnan Suma President, R&D | Sale | -50,000 | -1.53%3,217,729 | $197.77 | $9,888,276 | View SEC filing | |
| 2024-09-13 | Krishnan Krish S President and CEO | Sale | -50,000 | -1.53%3,219,647 | $197.77 | $9,888,276 | View SEC filing | |
| 2024-06-11 | Krishnan Suma President, R&D | Sale | -50,000 | -1.50%3,277,044 | $175.76 | $8,788,062 | View SEC filing |
1-25 of 82
Page 1 of 4